POSSIBILITIES OF TOPICAL THERAPY FOR DISCOID LUPUS ERYTHEMATOSUS

Download full text PDF
Issue: 
2
Year: 
2015

S. Lebedeva; Professor N. Teplyuk, MD; T. Belousova, Candidate of Medical Sciences; V. Novoselov, MD; A. Paramonov; O. Grabovskaya, Candidate of Medical Sciences I.M. Sechenov First Moscow State Medical University

Combination treatment using tacrolimus produced a pronounced clinical effect in a 60-year-old patient with the manifestations of discoid lupus erythematous on the scalp and keratoma at the nasal tip.
Keywords: 
discoid lupus erythematous
keratoma
tacrolimus

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Vardanjan K.L., Tkachenko S.B., Potekaev N.N. i dr. Vozmozhnosti neinvazivnyh metodov otsenki strukturnyh izmenenij kozhi pri krasnoj volchanke // Eksper. i klinich. dermatokosmetol. – 2009; 4: 4–8.
  2. Revmatologija. Nats. ruk-vo. Pod red. E.L. Nasonova, V.A. Nasonovoj / M.: GEOTAR-Media, 2008; 720 s.
  3. Romanenko I.M., Kulaga V.V., Afonin S.L. Lechenie kozhnyh i venericheskih boleznej: Ruk-vo dlja vrachej v 2 t. / M.: MIA, 2006; t. 1: 904 s.
  4. Djadyk A.I., Bagrij A.E. Sistemnaja krasnaja volchanka / Donetsk: Region, 2003; 464 s.
  5. Dzybik O.K. Kompleksnaja immunokorrigirujuschaja terapija, vkljuchajuschaja perftoran i lejkinferon, u bol'nyh s razlichnymi raznovidnostjami hronicheskoj krasnoj volchanki. Dis. … kand. med. nauk. M., 2009; 10 s.
  6. Belik I.E. Krasnaja volchanka. Osobennosti naznachenija bazisnoj terapii // Dermatologija i venerologija. – 2010; 2 (48): 30–5.
  7. Bak V.V. Kompleksnyj metod lechenija krasnoj volchanki s ispol'zovaniem benzaflavina (vitamin V2) i dekspantenola (vitamin V, regenerator). Avtoref. dis. … kand. med. nauk. M., 2003; 3 s.
  8. El'kin V.D., Mitrjukovskij L.S., Sedova T.G. Izbrannaja dermatologija / Perm', 2004; 964 s.
  9. Nasonova V.A., Astapenko M.G. Klinicheskaja revmatologija / M.: Meditsina, 1989; 420 s.
  10. Pal'tsev M.A., Potekaev N.N., Kazantseva I.A. i dr. Kliniko- morfologicheskaja diagnostika i printsipy lechenija kozhnyh boleznej / M.: Meditsina, 2006; 512 s.
  11. Dermatovenerologija. Nats. ruk-vo. Pod red. Ju.K. Skripkina, Ju.S. Butova, O.L. Ivanova / M.: GEOTAR-Media, 2011; 1024 s.
  12. Dermatovenerologija, 2010. Pod red. A.A. Kubanovoj / M.: DEKS-Press, 2010; 428 s.
  13. Evropejskoe rukovodstvo po lecheniju dermatologicheskih boleznej. Pod red. A.D. Katsambasa, T.M. Lotti. Per. s angl. / M.: MEDpress-inform, 2008; 736 s.
  14. Mavrov I.I., Bolotnaja L.A., Serbina I.M. Osnovy diagnostiki i lechnija v dermatologii i venerologii: Ruk-vo dlja vrachej i studentov / Har'kov: Fakt, 2007; 791 s.
  15. Luger T., Paul C. Potential new indications of topical calcineurin inhibitors // Dermatology. – 2007; 215 (1): 45–54.
  16. Avgerinou G., Papafragkaki D., Nasiopoulou A. et al. Effectiveness of topical calcineurin inhibitors as monotherapy or in combination with hydroxychloroquine in cutaneous lupus erythematosus // J. Eur. Acad. Dermatol. Venereol. – 2012; 26; 762–7.
  17. Ring J., Barker J., Behrendt H. et al. Review of the potential photococarcinogenicity of topical calcineurin inhibitors: position statement of the European Dermatology Forum // J. Eur. Acad. Dermatol. Venereol. – 2005; 19 (6) 663–71.
  18. Han Y., Kim H., Park S. et al. Four cases of facial discoid lupus erythematosus successfully treated with topical pimecrolimus or tacrolimus // Ann. Dermatol. – 2010; 22 (3): 307–11.
  19. Paller A., Lebwohl M., Fleischer A. Jr. et al. Tacrolimus ointment is more effective than pimecrolimus cream with a similar safety profile in the treatment of atopic dermatitis: results from 3 randomized, comparative studies // J. Am. Acad. Dermatol. – 2005; 52 (5): 810–22.
  20. Queille-Roussel C., Paul C., Duteil L. et al. The new topical ascomycin derivative SDZ ASM 981 does not induce skin atrophy when applied to normal skin for 4 weeks: a randomized, double-blind controlled study // Br J Dermatol. – 2001 144 (3): 507–13.
  21. Callen J., Chamlin S., Eichenfield L. et al. A systematic review of the safety of topical therapies for atopic dermatitis // Br. J. Dermatol. – 2007; 156 (2): 203–21.
  22. Scheinfeld N. The use of topical tacrolimus and pimecrolimus to treat psoriasis: a review // Dermatol. Online J. – 2004; 10 (1): 3.
  23. Marsland A., Griffiths C. The macrolide immunosuppressants in dermatology: mechanisms of actions // Eur. J. Dermatol. – 2002; 12: 618–22.
  24. Grassberger M., Steinhoff M., Schneider D. et al. Pimecrolimus – an antiinflammatory drug targeting the skin // Exp. Dermatol. – 2004; 13: 721–30.
  25. Sticherling M. Cutaneous lupus erythematosus and skin manifestations in systemic lupus erythematosus // Z. Rheumatol. – 2013; 72 (5): 429–35.
  26. Sticherling M., Bonsmann G., Kuhn A. Diagnostic approach and treatment of cutaneous lupus erythematosus // J. Deutsch. Dermatol. Ges. – 2008; 6: 48–61.
  27. Walling H., Sontheimer R. Cutaneous lupus erythematosus: issues in diagnosis and treatment // Am. J. Clin. Dermatol. – 2009; 10 (6): 365–81.
  28. Kuhn A., Ruland V., Bonsmann G. Cutaneous lupus erythematosus: update of therapeutic options part I // J. Am. Acad. Dermatol. – 2011; 65 (6): 179–93.
  29. Wollina U., Hansel G. The use of topical calcineurin inhibitors in lupus erythematosus: an overview // J. Eur. Acad. Dermatol. – 2008; 22: 1–6.
  30. Sigges J., Biazar C., Landmann A. et. al. Therapeutic strategies evaluated by the European Society of Cutaneous Lupus Erythematosus (EUSCLE) Core Set Questionnaire in more than 1000 patients with cutaneous lupus erythematosus // Autoimmun. Rev. –2013; 12 (7): 694–702.
  31. Sárdy M., Ruzicka T., Kuhn A. Topical calcineurin inhibitors in cutaneous lupus erythematosus // Arch. Dermatol. Res. – 2009; 301 (1): 93–8.
  32. Lampropoulos C., D’Cruz D. Topical calcineurin inhibitors in systemic lupus erythematosus // Ther. Clin. Risk Manag. – 2010; 6: 95–101.
  33. Kuhn A., Ochsendorf F., Bonsmann G. Treatment of cutaneous lupus erythematosus // Lupus. – 2010; 19 (9): 1125–36.
  34. Kuhn A., Ruland V., Bonsmann G. Skin manifestations in lupus erythematosus: clinical aspects and therapy // Z. Rheumatol. – 2011; 70 (3): 213– 26.
  35. Winkelmann R., Kim G., Del Rosso J. Treatment of cutaneous lupus erythematosus: review and assessment of treatment benefits based on oxford centre for evidence-based medicine criteria // J. Clin. Aesthet. Dermatol. – 2013; 6 (1): 27–38.
  36. Sticherling M. Update on the use of topical calcineurin inhibitors in cutaneous lupus erythematosus // Biologics. – 2011; 5: 21–31.
  37. Pothinamthong P., Janjumratsang P. A comparative study in efficacy and safety of 0,1% tacrolimus and 0,05% clobetasol propionate ointment in discoid lupus erythematosus by modified cutaneous lupus erythematosus disease area and severity index // J. Med. Assoc. Thai. – 2012; 95 (7): 933–40.
  38. Khondker L., Wahab M., Khan S. Efficacy of topical application of Pimecrolimus cream in the treatment of discoid lupus erythematosus // Mymensingh. Med. J. – 2012; 21 (2): 259–64.
  39. Tlacuilo-Parra A., Guevara-Gutiérrez E., Gutiérrez-Murillo F. et. al. Pimecrolimus 1% cream for the treatment of discoid lupus erythematosus // Rheumatology (Oxford). – 2005; 44 (12): 1564–8.
  40. Fabroni C., Lotti T. Pimecrolimus in dermatology // G. Ital. Dermatol. Venereol. – 2009; 144 (3): 321–5.
  41. Sehgal V., Pahwa M. Pimecrolimus, yet another intriguing topical immunomodulator // J. Dermatolog. Treat. – 2007; 18 (3): 147–50.